Carlos Mateo

Carlos Mateo

Auto-generated profile, based on publicly available information

Carlos Mateo

Instituto de Microcirugía Ocular (IMO) (C.M.), Barcelona, Spain

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2025 in Ophthalmology Retina
Verified
Journal Article
Open access
MCMatteo Mario Carlà
Matteo Mario Carlà
FBFrancesco Boselli
Francesco Boselli
FGFederico Giannuzzi
Federico Giannuzzi
ECEmanuele Crincoli
Emanuele Crincoli
FCFiammetta Catania
Fiammetta Catania
CMCarlos Mateo
Carlos Mateo
To evaluate the longitudinal progression of myopic maculopathy in a European cohort of highly myopic patients, analyzing disease natural history and its impact on visual function. Retrospective, observational monocentric cohort study. The study included 1228 eyes from 781 highly myopic patients with a minimum follow-up time of 5 years. We collected best-corrected visual acuity (BCVA) measurement, axial length (AXL), fundus photography, and spectral-domain optical coherence tomography (SD-OCT), along with data regarding IOP-lowering drugs and glaucoma surgery. Myopic atrophic maculopathy (MAM) was graded according to the ATN classification system. The presence of myopic staphyloma followed Curtin's classification. The development of myopic macular neovascularization (MNM) and myopic tractional maculopathy (MTM) was also assessed, along with the presence of dome-shaped macula (DSM) and lacquer cracks (LCs) at baseline. Rate of MAM progression and visual outcomes. Secondary outcome included the correlation with the presence of staphyloma subtypes and the development of MNM and MTM. Mean AXL was 31.6±2.8 mm. MAM progressed in 57% of eyes over a mean follow-up of 11.4 years. Eyes with patchy atrophy progressed in 81% of cases, and 47% of them developed macular atrophy, while eyes with tessellated fundus progressed in only 19% of cases. The presence of a macular-involving staphyloma was associated with progression, particular for type IX (86% rate of progression). A significant decline in BCVA (≥2 lines) was observed in 35.8% of eyes, and correlated with AXL, glaucoma surgery, patchy atrophy, MNM and MTM development (all p<0.05). Active MNM developed in 190 eyes (15%), significantly associated with baseline LCs (OR 2.56) and DSM (OR 4.95), determined faster progression toward macular atrophy (OR 5.91). MTM complications were observed in 314 eyes (26%) and significantly correlated with the presence of a type I and II staphyloma. More than half of eyes with myopic maculopathy tended to progress, in particular in cases with patchy atrophy at baseline and in eyes developing MNM or MTM, which caused worse vision loss during the study period. While DSM and LCs correlated with neovascular complications, the shape of posterior staphyloma correlated with tractional complications.

15 July 2024 in AJO International
Verified
Journal Article
Open access
MCMatteo Mario Carlà
Matteo Mario Carlà
CMCarlos Mateo
Carlos Mateo
FGFederico Giannuzzi
Federico Giannuzzi
FBFrancesco Boselli
Francesco Boselli
SRStanislao Rizzo
Stanislao Rizzo

18 October 2024 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
MCMatteo Mario Carlà
Matteo Mario Carlà
CMCarlos Mateo
Carlos Mateo
We report a case of retinal toxicity induced by SBP-101, a polyamine inhibitor for the treatment of metastatic pancreatic adenocarcinoma, presenting as rapidly progressive bilateral central retinal pigmented epithelium (RPE) atrophy in a patient with a silent ocular history. A 69-year-old female patient with a metastatic pancreatic adenocarcinoma visited our retina clinic referring a 6-months history of blurred vision and progressive visual field loss. One year before, she started administration of SBP-101 combined with nab-paclitaxel and gemcitabine to treat her malignancy. Baseline ophthalmological examination showed bilateral healthy retina an 20/20 visual acuity (VA). After the second monthly cycle of SBP-101, the patient experienced significant visual loss in both eyes, with VA decreasing to 20/50 in right eye (RE) and to 20/40 in left eye (LE). In the suspect of a cancer associated retinopathy (CAR), the patient underwent bilateral injection of intravitreal slow-releasing dexamethasone, with poor clinical outcomes. Concomitant testing for anti-enolase and anti-recoverin antibodies gave negative results, while electroretinography showed borderline but within the limit values in both eyes. At 6 months, VA was 20/5000 in RE and 20/4000 in LE and the patient referred significant limitations in everyday life. Ultra-wide field fundus photography showed a bilateral, roundish area of irregular pigment loss involving the entire macula and extending beyond the arcades. Ultra-wide autofluorescence showed a central area of hypo-autofluorescence surrounded by a ring of alternating hyper- and hypo-autofluorescence areas. Optical coherence tomography showed bilateral atrophy of the subfoveal RPE and disruption of the ellipsoid zone. Optic disc examination was within the limits. No treatment was possible. In conclusion, ophthalmologists should be aware of the existence of a sight-threatening side effect of SPB-101 administration, since we highlighted a massive bilateral RPE atrophy rapidly developing after the second drug injection.

27 September 2024 in American Journal of Ophthalmology
Verified
Journal Article
Open access
MCMatteo Mario Carlà
Matteo Mario Carlà
FBFrancesco Boselli
Francesco Boselli
FGFederico Giannuzzi
Federico Giannuzzi
ECEmanuele Crincoli
Emanuele Crincoli
TCTomaso Caporossi
Tomaso Caporossi
SRStanislao Rizzo
Stanislao Rizzo
To assess choroidal changes associated to optic disc pit maculopathy (ODP-M) and their evolution after surgical treatment. Multicentric retrospective case series. An analysis of 42 patients affected by unilateral ODP-M undergoing surgical treatment between 2013 and 2023 was conducted. Optical coherence tomography (OCT) was performed at baseline and postoperative months 1, 6, 12, and 24 and most recent follow-up. Subfoveal choroidal thickness (SFCT) and peripapillary choroidal thickness (PPCT) were measured in ODP-M and fellow eyes. The presence of retinal pigmented epithelium (RPE) atrophy was used to distinguish between "early" and "advanced" disease, and data regarding fluid localization were collected. Baseline SFCT in ODP-M eyes was significantly higher than fellow eyes (386.8 ± 88.9 vs 334.4 ± 72.2 µm, P = 0.002), in contrast to PPCT (192.6 ± 47.8 vs 181.2 ± 45.7 µm, P = .46). SFCT significantly decreased 1 month postoperatively (mean reduction 36.5 µm, P = .009) and remained below preoperative values throughout the follow-up, showed a mean reduction of 79.4 µm at final follow-up (P < .001). Conversely, PPCT showed no changes between preoperative and postoperative values (all P > .05). Nine eyes (21.4%) showed submacular dilated choroidal vessels, correlated with the presence of subretinal fluid (P = .008) and reducing in caliber after surgical treatment. The 10 eyes (23.8%) with advanced disease had lower baseline SFCT and worse best-corrected visual acuity compared to the early disease subgroup, and showed a delayed reduction of choroidal swelling postoperatively. Subfoveal choroid may thicken and remodel in response to ODP-M, eventually returning to physiological values after surgical treatment. Moreover, the presence of RPE atrophy may influence retino-choroidal balance. Conversely, PPCT did not show comparable modifications.

5 June 2025 in American Journal of Ophthalmology
Verified
Journal Article
Open access
MCMatteo Mario Carlà
Matteo Mario Carlà
FBFrancesco Boselli
Francesco Boselli
FGFederico Giannuzzi
Federico Giannuzzi
Laura De LucaLaura De Luca
Laura De Luca
ECEmanuele Crincoli
Emanuele Crincoli
SRStanislao Rizzo
Stanislao Rizzo
To characterize sequential pattern of fluid progression in optic disc pit maculopathy (ODP-M), identify threshold values for fluid migration between retinal layers, and determine the prognostic significance of optical coherence tomography (OCT) biomarkers. Multicenter, retrospective interventional case series. Forty-two eyes with ODP-M underwent surgical treatment with follow-up ≥12 months (mean 38.5 ± 30.6 months). OCT parameters including intraretinal fluid (IRF) height, foveal detachment (FD), intrapapillary proliferation (IPP), ellipsoid zone (EZ) integrity, and retinal pigment epithelium (RPE) disruption were analyzed preoperatively and at 1, 6, 12, and 24 months postoperatively. Visual and anatomical outcomes were evaluated using multivariate regression and Kaplan-Meier survival analysis. IRF followed a distinct progression pattern, sequentially involving the outer nuclear layer (ONL), inner nuclear layer (INL), and nerve fiber layer (NFL). Resolution after surgery occurred in reverse order (NFL→INL→ONL) with median resolution times of 3, 6, and 12 months, respectively. Surgical success rate after first intervention was 66.7%, with complete final fluid resolution in 72.2% of cases. ROC analysis identified threshold values for ONL→INL progression (152 µm, AUC = 0.84) and for INL→NFL progression (178 µm, AUC = 0.79). In multivariate analysis, independent predictors of final visual acuity included preoperative visual acuity (OR: 4.73, p < .001), absence of FD (OR: 0.31, p = .03), EZ visibility (OR: 0.42, p = .04), and absence of IPP (OR: 0.45, p = .05). ODP-M demonstrates a predictable pattern of fluid accumulation and resolution, with specific threshold values for fluid progression between retinal layers that may guide intervention timing and preoperative OCT biomarkers providing valuable prognostic information for visual outcomes.